Results 1 to 10 of about 28,207 (244)
Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients [PDF]
Biomedicines, 2022 Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain amyloidosis.
Mathijs O. Versteylen +3 more
doaj +4 more sources
Swiss Medical WeeklyCardiac amyloidosis is a disease characterised by the accumulation of amyloid protein in the heart tissue. There are several types of amyloidosis, but the most common types affecting the heart are ATTR amyloidosis (caused by transthyretin protein) and ...
Natallia Laptseva +3 more
doaj +8 more sources
Clinical Medicine, 2018 Cardiac amyloidosis is a prototype of restrictive cardiomyopathy and should be considered in any adult with unexplained heart failure and an echocardiography result suggestive of amyloidosis [...
Sofie Brouwers +5 more
core +10 more sources
Role of cardiac MRI in the diagnosis of cardiac amyloidosis. Clinical cases
Клинический разбор в общей медицине, 2021 Purpose. The aim of this work is to show the capabilities of late gadolinium enhancement cardiac magnetic resonance imaging (MRI) in the diagnosis of a rare disease such as cardiac amyloidosis. Materials and methods.
Ekaterina A. Butorova +1 more
doaj +2 more sources
Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021
Diagnostics, 2021 Cardiac amyloidosis is caused by the deposition of misfolded protein fibrils into the extracellular space of the heart. The diagnosis of cardiac amyloidosis remains challenging because of the heterogeneous manifestations of the disease.
Weijia Li +6 more
doaj +3 more sources
EXCLI Journal : Experimental and Clinical Sciences, 2023 Amyloidosis is a protein deposition disorder in which insoluble fibril structures accumulate in the bodily tissues damaging the organ function. Cardiac amyloidosis is a severe but under-reported medical condition characterized by the accumulation of ...
Gnana Deepthi Medarametla +9 more
doaj +4 more sources
Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
Case Reports in Medicine, 2021 Amyloidosis is an underappreciated medical condition with symptoms camouflaging as common medical comorbidities leading to its underdiagnosis due to its systemic involvement.
Constantine N. Logothetis +2 more
doaj +2 more sources
Catastrophic Cardiac Amyloidosis [PDF]
Cardiology Research and Practice, 2011 We report a case of a 61-year-old patient presenting with cardiogenic shock. His echocardiogram suggested typical features of cardiac amyloidosis.
Prashanth Panduranga, Mohammed Mukhaini
core +4 more sources
Clinical Medicine, 2005 Systemic amyloidosis commonly affects the heart. Indeed, cardiac symptoms may be the first clinical indicator of underlying amyloid deposition. Using two case studies, this article reviews the latest evidence regarding cardiac amyloidosis.
Maredia, Neil, Ray, Simon G
core +3 more sources
Transthyretin cardiac amyloidosis [PDF]
Cardiovascular Research, 2022 Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the development of effective treatments, have shifted ATTR-CA from a rare and ...
Porcari, Aldostefano +5 more
core +5 more sources